ALB
ALBEMARLE CORP
Next earnings Jul 28, 2026 (after close) · consensus $3.10 EPS, $1.58B rev
Last earnings -1.1% on 2026-05-06
$135.56
▲ +4.50%$135.56▲ +111.54%
over 1Y
L $61.83H $215.07
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.5%
1W-3.9%
1M-20.9%
3M-23.7%
YTD-5.3%
1Y+111.5%
Hold
Conviction
Horizon
Long (>12mo)
Street · 29 analysts
Buy
Lithium giant stuck in a brutal price trough — losses persist but cash flow and balance sheet buy time for a recovery bet.
Net income -$511M · FY2025
Albemarle is a leading lithium and bromine producer living through a violent commodity down-cycle. After net income peaked at $2.69B in FY2022, the company swung to a -$1.18B loss in FY2024 and a -$511M loss in FY2025, while revenue fell to $5.14B (-4.4% YoY) from $9.62B in FY2023. Operating income was -$367M and net margin -9.9%, so on an earnings basis this is currently an unprofitable business, and the negative -27.8x P/E is meaningless.
The redeeming features are cash and the balance sheet. Operating cash flow surged 86.4% to $1.28B even amid losses, capex was slashed 64.9% to $590M, and cash & equivalents rose 35.7% to $1.62B against $3.12B long-term debt and $9.53B of equity. That combination — positive operating cash, lower capex, and ample liquidity — gives Albemarle the runway to wait out the trough, and the dividend ($191M) was maintained.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:43 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.33B | $7.32B | $9.62B | $5.38B | $5.14B |
| Gross profit | $998M | $3.07B | $1.19B | $62.5M | $669M |
| Operating income | $798M | $2.47B | $252M | -$1.78B | -$367M |
| Net income | $124M | $2.69B | $1.57B | -$1.18B | -$511M |
| Diluted EPS | $1.06 | $22.84 | $13.36 | -$11.20 | -$5.76 |
| Net margin | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$17.6B
EV / EBITDA60.2
EV / Sales3.4
EV / FCF25.4
P / FCF23.1
PEG (trailing)—
Earnings yield-3.2%
FCF yield4.3%
Quality & risk
ROIC (est.)-2.3%
Free cash flow$692M
Total debt$3.19B
Net cash-$1.58B
Piotroski F-Score5/9
Capital returns
Buyback yield0.0%
Dividend yield (est.)1.2%
Shareholder yield1.2%
Shares Δ YoY+0.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — restated periodic report (2026-03-31). Worth a closer look.
- 8-K Officer / director change2026-06-05
- 8-K Officer / director change2026-05-08
- 8-K Earnings results2026-05-06
- 10-Q Quarterly report2026-05-06
- 8-K Officer / director change2026-04-17
- 10-K/A Restated periodic report2026-03-31
- 8-K Material agreement2026-03-25
- DEF 14A Proxy statement2026-03-24
- 8-K Acquisition / disposition2026-03-06
Recent filings
all on EDGAR ↗11-KPeriod ending 2025-12-312026-06-25open ↗8-KPeriod ending 2026-06-012026-06-05open ↗SDFiling2026-05-29open ↗4Period ending 2026-05-152026-05-19open ↗144Filing2026-05-15open ↗SCHEDULE 13G/AFiling2026-05-14open ↗S-8Filing2026-05-08open ↗8-KPeriod ending 2026-05-052026-05-08open ↗10-QPeriod ending 2026-03-312026-05-06open ↗8-KPeriod ending 2026-05-062026-05-06open ↗SCHEDULE 13GFiling2026-04-29open ↗SCHEDULE 13GFiling2026-04-28open ↗
Frequently asked
- Is ALBEMARLE CORP (ALB) a buy?
- ALB currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Lithium giant stuck in a brutal price trough — losses persist but cash flow and balance sheet buy time for a recovery bet.
- What is ALBEMARLE CORP's quality score?
- ALB scores 51.709363810854114/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000915913, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/21/2026, 8:43:43 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.